ClinicalTrials.gov
public full text
Public Domain
Study of ADCT-301 in Patients With Selected Advanced Solid Tumors
bladder-canceresophageal-cancergastric-cancermelanomanon-small-cell-lung-cancerovarian-cancerpancreas-cancerrenal-cell-carcinoma
This study evaluates ADCT-301 in patients with Selected Advanced Solid Tumors. Patients will participate in a Treatment Period with 3-week cycles and a Follow-up Period every 12 weeks for up to 1 year after treatment discontinuation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial#235402
- PRO1107 in Patients With Advanced Solid Tumors#852344
- Expanded Access Study of TAS-120 in Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements#829811
- First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors#1140906
- Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors#896682
Record · ID 814039
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive